DIMET (SIAM) PUBLIC COMPANY LIMITED DITTO (THAILAND) PUBLIC COMPANY LIMITED DO DAY DREAM PUBLIC COMPANY LIMITED DOD BIOTECH PUBLIC COMPANY LIMITED DOHOME PUBLIC COMPANY LIMITED DON MUANG TOLLWAY PUBLIC
DIMET (SIAM) PUBLIC COMPANY LIMITED DITTO (THAILAND) PUBLIC COMPANY LIMITED DO DAY DREAM PUBLIC COMPANY LIMITED DOD BIOTECH PUBLIC COMPANY LIMITED DOHOME PUBLIC COMPANY LIMITED DON MUANG TOLLWAY PUBLIC
COMPANY LIMITED DIMET: DIMET (SIAM) PUBLIC COMPANY LIMITED DITTO: DITTO (THAILAND) PUBLIC COMPANY LIMITED DMT: DON MUANG TOLLWAY PUBLIC COMPANY LIMITED DOD: DOD BIOTECH PUBLIC COMPANY LIMITED DOHOME: DOHOME
Advisor on the connected transaction which is prepared by Jay Capital Advisory Limited (details are as per attachment no.16) 15. Proxy Form together with the list of independent directors being nominated as
contacted the Company to request time for 3 months for repayment of the loan due to MAT being in the process of restructuring and the new operating system setting. In addition, MAT was in the process of the
”). The highest transaction value equals to 45.04 percent based on the net tangible asset basis, being considered as a Class 2 transaction in accordance with the Notification on Acquisition or Disposal of
16.18 percent based on the net tangible asset basis, being considered as a Class 2 transaction under the Notification on Acquisition or Disposal of Assets. As a result, the Company is required to
shareholders of the Bank and Permata granting approval for the Transaction and the approvals of the Bank of Thailand (“BOT”) and of Otoritas Jasa Keuangan (“OJK”) of Indonesia being granted for all matters
financial statements and operation result of Nam San 3A for fiscal year of 2016, 2017 and 20183 (using the average exchange rate being at LAK 291.46 to THB 1 as of 17 January 2020 announced by the Bank of
, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 9. Expected Benefits for the Company: The company expects to benefit from the opportunity of being more competitive